The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Intractable Epilepsy
- Sponsor
- Institute of Child Health
- Enrollment
- 64
- Locations
- 1
- Primary Endpoint
- Effect of reduction in anti-epileptic medications on quality of life in young people with intractable epilepsy
- Last Updated
- 18 years ago
Overview
Brief Summary
The primary aim of the study is to determine the effect of reducing the number and/or dose of anti epileptic drugs on an individual's quality of life and seizure control in people with difficult to control epilepsy and who are on polytherapy.
This is a randomised trial so children will be divided into two groups, with reduction of anti epileptic drugs in the first group (withdrawal group) and no change to their medications in the second (control group). Irrespective of the group the child is assigned to (withdrawal group or control group), we will ask parents to complete several questionnaires on 2 occasions: the first time will be immediately after the child enters the study (i.e. baseline assessment), and a second and last one will be 6 months after entering the study (i.e. follow-up assessment). These questionnaires aim to "quantify" aspects related with quality of life, AED side effects, seizure severity, and behaviour.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Young people aged 6-21 years with intractable epilepsy receiving antiepileptic drug polytherapy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Effect of reduction in anti-epileptic medications on quality of life in young people with intractable epilepsy
Time Frame: 6 months
Secondary Outcomes
- Identify other determinants of quality of life in this group of subjects(6 months)